Mexico Parkinsons Disease Market (2025-2031) | Industry, Trends, Analysis, Growth, Size & Revenue, Companies, Forecast, Outlook, Competitive Landscape, Value, Share, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Mexico Country Macro Economic Indicators

3.2 Mexico Parkinsons Disease Market Revenues & Volume, 2021 & 2031F

3.3 Mexico Parkinsons Disease Market - Industry Life Cycle

3.4 Mexico Parkinsons Disease Market - Porter's Five Forces

3.5 Mexico Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Mexico Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F

3.7 Mexico Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Mexico Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 Mexico Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of Parkinson's disease in Mexico

4.2.2 Growing awareness and diagnosis rates of Parkinson's disease

4.2.3 Advancements in treatment options and therapies for Parkinson's disease

4.3 Market Restraints

4.3.1 High cost of Parkinson's disease medications and treatments

4.3.2 Limited access to specialized healthcare facilities in some regions of Mexico

4.3.3 Lack of trained healthcare professionals in managing Parkinson's disease patients

6.1 Mexico Parkinsons Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Mexico Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Mexico Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F

6.1.4 Mexico Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F

6.1.5 Mexico Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F

6.1.6 Mexico Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F

6.1.7 Mexico Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F

6.1.8 Mexico Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F

6.2 Mexico Parkinsons Disease Market, By Medical Devices

6.2.1 Overview and Analysis

6.2.2 Mexico Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F

6.2.3 Mexico Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F

6.3 Mexico Parkinsons Disease Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Mexico Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Mexico Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3.4 Mexico Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3.5 Mexico Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F

6.3.6 Mexico Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 Mexico Parkinsons Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Mexico Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 Mexico Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Mexico Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.5 Mexico Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.5 Mexico Parkinsons Disease Market, By Patient Care Setting

6.5.1 Overview and Analysis

6.5.2 Mexico Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 Mexico Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

7.1 Mexico Parkinsons Disease Market Export to Major Countries

7.2 Mexico Parkinsons Disease Market Imports from Major Countries

8.1 Number of new Parkinson's disease cases diagnosed annually in Mexico

8.2 Adoption rate of new Parkinson's disease treatments in the market

8.3 Patient satisfaction with Parkinson's disease management services provided

8.4 Number of clinical trials and research studies focused on Parkinson's disease in Mexico

8.5 Percentage of Parkinson's disease patients receiving regular follow-up care and support

9.1 Mexico Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Mexico Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F

9.3 Mexico Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Mexico Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 Mexico Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F

10.1 Mexico Parkinsons Disease Market Revenue Share, By Companies, 2024

10.2 Mexico Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters